Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Timing bond vs index fund choices in retirement affects risk and growth. Learn when to shift allocations for income.
25,546 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Last month, poet technologies skyrocketed 72.6%, delivering a dramatic rally in a volatile sector. This article expla...
Anthropic’s Boris Cherny says he oversees a growing fleet of AI agents, signaling a dramatic shift in software develo...
Apple rolled out a beta Siri upgrade with limited regional access, keeping EU and China on the sidelines. Investors a...
MP Materials sits at the intersection of U.S. manufacturing ambitions and global rare-earth supply. This guide breaks...
Bitcoin dipped toward the $61,000 mark as XRP and ADA fell sharply, signaling renewed risk-off in crypto markets. The...
Amazon expands its AI funding spree, locking in another $17.5 billion in external financing as total external funding...
As UAD 3.6 rolls out, lenders should view reset as a strategic inflection point — a chance to retool data, adjust ris...
Nvidia stock could reach $250 per share as AI-driven data-center demand accelerates earnings, but regulatory and macr...
SpaceX is exploring a historic mega-IPO with a razor-thin gross spread. Goldman leads a bid to win the deal at one of...
SpaceX gears up for the largest IPO in history on Nasdaq, while a 1:1 tokenized SpaceX equity trades on Solana. Backp...
A top cloud platform just posted a record-breaking quarter as Micron pulls back, prompting investors to shift toward ...